News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Millennium Laboratories Offering Flexibility In Sample Collection With Buccal Swabs For Pharmacogenetic Testing

8/25/2014 8:37:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, Aug. 25, 2014 /PRNewswire/ -- Millennium Laboratories announced today that it now offers buccal swabs as an additional specimen collection option for its pharmacogenetic test, Millennium PGTSM. The buccal swab provides health care professionals with an alternative to saliva, improving ease of collection. Millennium PGT is a non- invasive genetic test utilizing either a buccal or saliva specimen to identify how a patient's genetic profile may impact his or her response to certain medications.

Millennium PGT.

Millennium recently added seven new genes, increasing the Millennium offering to 11 genes total. Pharmacogenetic testing helps clinicians choose the right medication at the right dose for their patients, thereby helping to avoid prescribing ineffective medications that might delay the patient's recovery or response to medication. Millennium PGT is integrated with the Millennium Analysis of Patient Phenotype (MAPP®) report and PGT ConsultSM mobile app to provide clinicians with evidence-based and clinically actionable information to make personalized prescribing decisions. 

"The addition of the buccal swab to our PGT collection options furthers our goal of helping providers deliver optimal medication therapy to patients," said Brock Hardaway, chief executive officer. "This option provides flexibility in specimen collection, allowing clinician choice in determining the best sample collection for each individual patient."

About Millennium PGT
Millennium PGT is a laboratory developed, non-invasive, pharmacogenetic test that analyzes clinically important genetic variations associated with patient response to many commonly prescribed medicines. Millennium PGT provides clinicians with objective information that may help them individualize medication treatment decisions.

Millennium PGT is paired with the MAPP® Report, which provides clinicians with clinically-actionable information, based on a patient's own genetics, about their potential response to over 30 medications prescribed across four key therapeutic areas: pain, mental health, addiction and cardiovascular therapy. Together with PGT Consult, a mobile application that provides evidence-based clinical decision support, Millennium helps clinicians individualize medications to their patient's unique genetics, maximizing the opportunity for successful outcomes.

About Millennium Laboratories
Millennium Laboratories, a leader in the science of medication monitoring and pharmacogenetics, is transforming the way health care professionals monitor and manage their patients' medication therapy. Through the use of advanced technology, supported by research and education, Millennium helps practitioners personalize care for patients. Building on this strong foundation, Millennium aims to expand its impact by helping more people affected by chronic illnesses and dedicating itself to filling a crucial unmet need in health care. More information can be found at

Millennium Laboratories.

Logo -
Logo -

SOURCE Millennium Laboratories, LLC

Help employers find you! Check out all the jobs and post your resume.

Read at

comments powered by Disqus